449 related articles for article (PubMed ID: 8633384)
1. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
Saitovitch D; Morris PJ; Wood KJ
Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
[TBL] [Abstract][Full Text] [Related]
2. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
Wong W; Morris PJ; Wood KJ
Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
4. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.
Pearson TC; Madsen JC; Larsen CP; Morris PJ; Wood KJ
Transplantation; 1992 Sep; 54(3):475-83. PubMed ID: 1384183
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness.
Saitovitch D; Bushell A; Mabbs DW; Morris PJ; Wood KJ
Transplantation; 1996 Jun; 61(11):1642-7. PubMed ID: 8669111
[TBL] [Abstract][Full Text] [Related]
6. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
7. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential.
Bushell A; Morris PJ; Wood KJ
Transplantation; 1994 Jul; 58(2):133-9. PubMed ID: 8042231
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
Wong W; Morris PJ; Wood KJ
Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
[TBL] [Abstract][Full Text] [Related]
9. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
11. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
Madsen JC; Superina RA; Wood KJ; Morris PJ
Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
[TBL] [Abstract][Full Text] [Related]
12. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
Arima T; Goss JA; Walp LA; Flye MW
Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
Motoyama K; Arima T; Lehmann M; Flye MW
Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
[TBL] [Abstract][Full Text] [Related]
14. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
15. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence.
Bushell A; Pearson TC; Morris PJ; Wood KJ
Transplantation; 1995 May; 59(10):1367-71. PubMed ID: 7770920
[TBL] [Abstract][Full Text] [Related]
16. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
Yang CP; Shittu E; Bell EB
J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulation by CD4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo: evidence for a reduction in the frequency of alloantigen-specific cytotoxic T cells in vitro.
Roelen DL; Bushell AR; Niimi M; Young NT; Rust NA; Morris PJ; Wood KJ
Hum Immunol; 1998 Sep; 59(9):529-39. PubMed ID: 9757909
[TBL] [Abstract][Full Text] [Related]
18. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
19. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
[TBL] [Abstract][Full Text] [Related]
20. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response.
Bushell A; Morris PJ; Wood KJ
Eur J Immunol; 1995 Sep; 25(9):2643-9. PubMed ID: 7589139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
